Literature DB >> 30389824

Variability and Repeatability of Quantitative Uptake Metrics in 18F-FDG PET/CT of Non-Small Cell Lung Cancer: Impact of Segmentation Method, Uptake Interval, and Reconstruction Protocol.

Mingzan Zhuang1,2, David Vállez García1, Gerbrand M Kramer3, Virginie Frings3, E F Smit4, Rudi Dierckx1, Otto S Hoekstra3, Ronald Boellaard5,3.   

Abstract

There is increased interest in various new quantitative uptake metrics beyond SUV in oncologic PET/CT studies. The purpose of this study was to investigate the variability and test-retest ratio (TRT) of metabolically active tumor volume (MATV) measurements and several other new quantitative metrics in non-small cell lung cancer using 18F-FDG PET/CT with different segmentation methods, user interactions, uptake intervals, and reconstruction protocols.
Methods: Ten patients with advanced non-small cell lung cancer received 2 series of 2 whole-body 18F-FDG PET/CT scans at 60 min after injection and at 90 min after injection. PET data were reconstructed with 4 different protocols. Eight segmentation methods were applied to delineate lesions with and without a tumor mask. MATV, SUVmax, SUVmean, total lesion glycolysis, and intralesional heterogeneity features were derived. Variability and repeatability were evaluated using a generalized-estimating-equation statistical model with Bonferroni adjustment for multiple comparisons. The statistical model, including interaction between uptake interval and reconstruction protocol, was applied individually to the data obtained from each segmentation method.
Results: Without masking, none of the segmentation methods could delineate all lesions correctly. MATV was affected by both uptake interval and reconstruction settings for most segmentation methods. Similar observations were obtained for the uptake metrics SUVmax, SUVmean, total lesion glycolysis, homogeneity, entropy, and zone percentage. No effect of uptake interval was observed on TRT metrics, whereas the reconstruction protocol affected the TRT of SUVmax Overall, segmentation methods showing poor quantitative performance in one condition showed better performance in other (combined) conditions. For some metrics, a clear statistical interaction was found between the segmentation method and both uptake interval and reconstruction protocol.
Conclusion: All segmentation results need to be reviewed critically. MATV and other quantitative uptake metrics, as well as their TRT, depend on segmentation method, uptake interval, and reconstruction protocol. To obtain quantitative reliable metrics, with good TRT performance, the optimal segmentation method depends on local imaging procedure, the PET/CT system, or reconstruction protocol. Rigid harmonization of imaging procedure and PET/CT performance will be helpful in mitigating this variability.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  non-small cell lung cancer; positron emission tomography imaging; repeatability; segmentation method; variability

Year:  2018        PMID: 30389824     DOI: 10.2967/jnumed.118.216028

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

1.  Risk analysis in peripheral clinical T1 non-small cell lung cancer correlations between tumor-to-blood standardized uptake ratio on 18F-FDG PET-CT and primary tumor pathological invasiveness: a real-world observational study.

Authors:  Xiao-Feng Li; Yun-Mei Shi; Rong Niu; Xiao-Nan Shao; Jian-Feng Wang; Xiao-Liang Shao; Fei-Fei Zhang; Yue-Tao Wang
Journal:  Quant Imaging Med Surg       Date:  2022-01

Review 2.  Identification of Tumor-Specific MRI Biomarkers Using Machine Learning (ML).

Authors:  Rima Hajjo; Dima A Sabbah; Sanaa K Bardaweel; Alexander Tropsha
Journal:  Diagnostics (Basel)       Date:  2021-04-21

3.  Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper.

Authors:  Laure Fournier; Lioe-Fee de Geus-Oei; Daniele Regge; Daniela-Elena Oprea-Lager; Melvin D'Anastasi; Luc Bidaut; Tobias Bäuerle; Egesta Lopci; Giovanni Cappello; Frederic Lecouvet; Marius Mayerhoefer; Wolfgang G Kunz; Joost J C Verhoeff; Damiano Caruso; Marion Smits; Ralf-Thorsten Hoffmann; Sofia Gourtsoyianni; Regina Beets-Tan; Emanuele Neri; Nandita M deSouza; Christophe M Deroose; Caroline Caramella
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

Review 4.  A systematic review and quality of reporting checklist for repeatability and reproducibility of radiomic features.

Authors:  Elisabeth Pfaehler; Ivan Zhovannik; Lise Wei; Ronald Boellaard; Andre Dekker; René Monshouwer; Issam El Naqa; Jan Bussink; Robert Gillies; Leonard Wee; Alberto Traverso
Journal:  Phys Imaging Radiat Oncol       Date:  2021-11-09

5.  Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [18F]FDG PET/CT in Early Triple-Negative Breast Cancer.

Authors:  Clément Bouron; Clara Mathie; Valérie Seegers; Olivier Morel; Pascal Jézéquel; Hamza Lasla; Camille Guillerminet; Sylvie Girault; Marie Lacombe; Avigaelle Sher; Franck Lacoeuille; Anne Patsouris; Aude Testard
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

6.  Effect of Bayesian penalty likelihood algorithm on 18F-FDG PET/CT image of lymphoma.

Authors:  Yongtao Wang; Lejun Lin; Wei Quan; Jinyu Li; Weilong Li
Journal:  Nucl Med Commun       Date:  2022-03-01       Impact factor: 1.690

Review 7.  Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential.

Authors:  Xingping Zhang; Yanchun Zhang; Guijuan Zhang; Xingting Qiu; Wenjun Tan; Xiaoxia Yin; Liefa Liao
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.